Financial Statements — CHRN
Balance Sheet
(in millions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Cash & Equivalents | 3.99 | 2.72 | 5.24 | 8.05 | 8.29 | 5.89 | 8.80 | 9.94 | 13.31 | 16.28 | 29.18 | 31.91 | 43.44 | 45.94 | 36.18 |
| Accounts Receivable | 4.54 | 6.05 | 4.53 | 6.46 | 6.96 | 6.52 | 5.77 | 5.87 | 5.05 | 4.83 | 3.40 | 3.34 | 3.12 | 2.76 | 3.35 |
| Inventory | 4.65 | 5.02 | 5.44 | 4.96 | 5.03 | 4.97 | 5.11 | 5.49 | 5.60 | 5.66 | 3.51 | 3.27 | 1.75 | 1.95 | 2.77 |
| Total Current Assets | 14.05 | 14.80 | 15.97 | 20.07 | 21.07 | 18.64 | 20.52 | 22.36 | 24.72 | 27.60 | 36.75 | 39.32 | 49.10 | 51.30 | 43.12 |
| Property, Plant & Equipment | 1.12 | 1.24 | 1.44 | 1.45 | 1.63 | 1.75 | 1.86 | 2.09 | 2.30 | 2.45 | 0.96 | 0.91 | 1.17 | 1.06 | 0.89 |
| Goodwill | 0.43 | 0.43 | 0.43 | 0.43 | 0.43 | 0.43 | 0.43 | 0.43 | 0.43 | 0.43 | -- | -- | -- | -- | -- |
| Intangible Assets | 1.68 | 1.84 | 1.93 | 2.01 | 2.35 | 2.43 | 2.51 | 2.66 | 2.74 | 2.83 | -- | -- | -- | -- | -- |
| Total Non-current Assets* | 5.62 | 6.87 | 7.19 | 7.24 | 8.14 | 8.34 | 8.44 | 8.82 | 9.27 | 9.51 | 2.56 | 1.20 | 1.63 | 1.68 | 1.12 |
| Total Assets | 19.67 | 21.66 | 23.17 | 27.31 | 29.21 | 26.98 | 28.96 | 31.18 | 33.99 | 37.10 | 39.31 | 40.52 | 50.73 | 52.97 | 44.24 |
| Accounts Payable | 2.11 | 1.66 | 1.45 | 2.00 | 1.81 | 2.13 | 1.88 | 2.50 | 3.16 | 3.04 | 2.39 | 2.05 | 1.31 | 1.43 | 2.94 |
| Total Current Liabilities | 9.09 | 8.94 | 6.71 | 8.55 | 7.51 | 7.70 | 7.31 | 7.83 | 10.13 | 9.54 | 7.86 | 4.82 | 4.68 | 4.68 | 5.97 |
| Long-term Debt | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 2.00 | 2.00 | 1.99 | 1.99 | 1.99 |
| Total Non-current Liabilities* | 4.84 | 3.04 | 5.52 | 6.07 | 6.83 | 7.22 | 7.59 | 8.09 | 6.05 | 6.28 | 2.84 | 3.97 | 7.00 | 8.20 | 4.79 |
| Total Liabilities | 13.93 | 11.98 | 12.24 | 14.62 | 14.34 | 14.93 | 14.91 | 15.93 | 16.18 | 15.82 | 10.70 | 8.79 | 11.67 | 12.88 | 10.76 |
| Retained Earnings | (269.28) | (257.72) | (256.30) | (253.59) | (247.06) | (244.99) | (242.57) | (235.93) | (232.57) | (228.34) | (220.77) | (216.46) | (206.00) | (204.05) | (213.49) |
| Total Stockholder Equity | 2.09 | 9.68 | 10.93 | 12.69 | 14.87 | 12.06 | 14.05 | 15.26 | 17.81 | 21.28 | 28.61 | 31.73 | 39.06 | 40.10 | 37.22 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q4
2021 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Total Revenue | 2.14 | 3.14 | 4.23 | 2.06 | 3.38 | 5.09 | 4.13 | 4.95 | 3.76 | 4.85 | 4.61 | 4.70 | 4.12 | 3.55 | 3.33 | 3.47 | 4.08 | 3.05 | 2.21 | 2.57 |
| Cost of Revenue | 1.07 | 1.47 | 1.68 | 1.24 | 1.57 | 2.38 | 1.92 | 2.31 | 1.81 | 2.48 | 2.15 | 2.45 | 2.12 | 1.87 | 1.64 | 1.82 | 1.66 | 1.24 | 0.92 | 1.36 |
| Gross Profit | 1.07 | 1.67 | 2.55 | 0.82 | 1.81 | 2.71 | 2.21 | 2.64 | 1.95 | 2.37 | 2.46 | 2.25 | 2.00 | 1.68 | 1.69 | 1.64 | 2.42 | 1.81 | 1.29 | 1.21 |
| Research & Development | 0.58 | 0.64 | 0.55 | 0.85 | 0.99 | 0.85 | 0.78 | 1.12 | 1.14 | 1.31 | 1.16 | 1.40 | 1.15 | 0.77 | 0.94 | 0.92 | 0.82 | 0.62 | 0.71 | 1.00 |
| Selling, General & Admin | 4.06 | 3.10 | 2.09 | 2.25 | 2.55 | 2.22 | 2.31 | 2.01 | 2.25 | 2.52 | 2.18 | 2.79 | 3.21 | 3.40 | 2.66 | 2.11 | 4.11 | 2.29 | 2.14 | 2.82 |
| Total Operating Expenses | 6.69 | 6.18 | 3.95 | 4.79 | 5.25 | 4.94 | 4.85 | 4.97 | 5.21 | 5.82 | 5.39 | 6.54 | 6.45 | 6.11 | 5.34 | 4.87 | 6.97 | 4.60 | 4.64 | 5.45 |
| Operating Income | (5.62) | (4.51) | (1.40) | (3.97) | (3.44) | (2.23) | (2.64) | (2.33) | (3.26) | (3.45) | (2.93) | (4.28) | (4.45) | (4.44) | (3.65) | (3.23) | (4.55) | (2.79) | (3.35) | (4.24) |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | 0.06 | 0.05 | 0.06 | 0.06 | 0.13 | 0.07 | 0.03 | 0.03 | 0.04 | 0.02 | 0.03 | 0.03 |
| Net Income | (6.88) | (4.67) | (1.42) | (2.71) | (2.89) | (3.41) | (2.07) | (2.42) | (3.43) | (3.21) | (3.36) | (4.23) | (4.39) | (3.18) | (4.30) | (2.98) | (2.86) | (1.96) | (1.27) | (3.67) |
| Basic EPS | (2.04) | (3.01) | (0.54) | (1.24) | (0.12) | (0.13) | (0.10) | (0.13) | (0.20) | (0.22) | (0.24) | (0.31) | (0.33) | (0.24) | (0.33) | (0.23) | (0.21) | (0.15) | (0.10) | (0.36) |
| Diluted EPS | (2.04) | (3.01) | (0.54) | (1.24) | (0.12) | -- | (0.10) | (0.13) | (0.20) | (0.22) | (0.24) | (0.31) | (0.33) | (0.24) | (0.33) | (0.23) | (0.26) | (0.17) | (0.11) | (0.36) |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q4
2021 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Operating Cash Flow | (2.12) | (4.33) | (2.06) | (3.44) | (1.96) | (1.43) | (2.28) | (2.67) | (3.47) | (1.58) | (3.35) | (2.90) | (4.21) | (3.64) | (2.59) | (8.45) | (3.07) | (2.47) | (1.40) | (4.21) |
| Capital Expenditures | 0.00 | 0.13 | 0.01 | 0.04 | 0.01 | 0.02 | 0.01 | 0.00 | 0.01 | 0.04 | 0.02 | 0.06 | 0.04 | 0.05 | 0.14 | -- | -0.00 | 0.06 | -- | -- |
| Free Cash Flow* | (2.12) | (4.46) | (2.07) | (3.48) | (1.97) | (1.45) | (2.28) | (2.67) | (3.47) | (1.63) | (3.37) | (2.96) | (4.26) | (3.70) | (2.73) | -- | (3.07) | (2.53) | -- | -- |
| Investing Cash Flow | 0.00 | (0.13) | (0.01) | (0.04) | (0.01) | (0.02) | (0.01) | 0.00 | (0.01) | (0.04) | (0.02) | (0.05) | (0.04) | (5.03) | (0.14) | -- | 0.00 | (0.06) | -- | -- |
| Financing Cash Flow | 4.95 | 2.92 | (0.44) | 0.62 | 3.53 | (0.31) | 0.00 | (0.26) | 3.66 | -- | -- | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 38.71 | 0.00 |
* Derived from reported values
